AXT Inc director awarded 29,112 shares; ownership now 122,512

AXT Inc (AXTI) director Leonard J. LeBlanc received a prorated equity grant of 29,112 shares of common stock on 07/29/2025.

Rhea-AI Filing Summary

AXT Inc (AXTI) director Leonard J. LeBlanc received a prorated equity grant of 29,112 shares of common stock on 07/29/2025. The grant was calculated using the closing share price of $2.29 on that date and vests on May 15, 2026, subject to continuous service through the vesting date. After the grant, the filing reports Mr. LeBlanc beneficially owns 122,512 shares. The transaction was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The grant aligns the director’s compensation with shareholder value through a time-based vesting schedule.

Positive

• Director equity grant aligns the reporting person’s incentives with shareholders via time-based vesting
• Grant vests within a defined period (May 15, 2026), providing clear conditions tied to continued service

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity grant aligns incentives; not materially dilutive given disclosed ownership.

This is a standard prorated equity award to a director, calculated at the closing price of $2.29 and vesting in under a year if service continues. Such awards are common governance practice to align management and director interests with shareholders. The filing shows post-grant beneficial ownership of 122,512 shares, indicating the grant is modest relative to existing holdings disclosed here. No derivative transactions, sales, or unusual vesting acceleration are disclosed. Impact on outstanding share count or dilution is not provided in this Form 4, so materiality to shareholders cannot be fully assessed from this filing alone.

Securities Analyst

TL;DR: Transaction is informational and routine; insufficient data here to affect valuation materially.

The report documents a 29,112-share award vested over a specified schedule and based on a $2.29 closing price. This is a non-derivative grant with time-based vesting to May 15, 2026. The filing does not state total shares outstanding or grant dilution percentage, so the transaction appears immaterial to company valuation from this disclosure alone. The Form 4 was signed by a power of attorney, which is standard for timely reporting.

Insider Trade Summary

Grant/Award: 29,112 shares

Grant/Award 1 txn

Insider LEBLANC LEONARD J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,112	$0.00	$0.00

Holdings After Transaction: Common Stock — 122,512 shares (Direct)

Footnotes (1)

1. F1. Represents an equity grant of common stock based on a prorated grant calculated based on $2.29, which was the closing price of the Issuer's common stock on July 29, 2025, and vests on May 15, 2026, subject to the Reporting Person's continuous service through the vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leonard J. LeBlanc report on Form 4 for AXTI?

He reported receiving a prorated grant of 29,112 shares of common stock on 07/29/2025, calculated at the closing price of $2.29.

When does the equity grant to the AXTI director vest?

The award vests on May 15, 2026, subject to the reporting person’s continuous service through that date.

How many AXTI shares does Leonard J. LeBlanc beneficially own after the reported transaction?

The Form 4 reports 122,512 shares beneficially owned following the grant.

Was the Form 4 for AXTI signed by the reporting person?

The filing shows it was signed 08/14/2025 by Jeff Sensiba by power of attorney for Leonard J. LeBlanc.

Does this Form 4 report any derivative transactions for AXTI?

No. Table II for derivative securities contains no reported transactions; only a non-derivative common stock grant is listed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2025 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEBLANC LEONARD J

(Last) (First) (Middle)

4281 TECHNOLOGY DRIVE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXT INC [ AXTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/29/2025		A		29,112	A	(1)	122,512	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an equity grant of common stock based on a prorated grant calculated based on $2.29, which was the closing price of the Issuer's common stock on July 29, 2025, and vests on May 15, 2026, subject to the Reporting Person's continuous service through the vesting date.

	/s/ Jeff Sensiba, by power of attorney for Leonard J LeBlanc	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.